Evidence map›Paper›PMID 23050649›Full record

ArticleJournal of neurochemistry2012

Post-ischemic vascular adhesion protein-1 inhibition provides neuroprotection in a rat temporary middle cerebral artery occlusion model.

Jittiya Watcharotayangul, Lizhen Mao, Haoliang Xu, Francesco Vetri, Verna L Baughman, Chanannait Paisansathan, Dale A Pelligrino

Open access · greenAbstract read
In one paragraph

Article in Journal of neurochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Neuroinflammation and Neuropathology.Neuroscience and behavioral physiology · 2022
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Dynamic capillary stalls in reperfused ischemic penumbra contribute to injury: A hyperacute role for neutrophils in persistent traffic jams.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  10. Review
  11. Review
  12. Neuroinflammation: friend and foe for ischemic stroke.Journal of neuroinflammation · 2019
    Review
  13. Review
  14. Article
  15. Article
  16. Targeting neutrophils in ischemic stroke: translational insights from experimental studies.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2015
    Review
  17. Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2014
    Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jittiya WatcharotayangulNeuroanesthesia Research Laboratory, University of Illinois, Chicago, Illinois, USA.
Lizhen Mao
Haoliang Xu
Francesco Vetri
Verna L Baughman
Chanannait Paisansathan
Dale A Pelligrino
University of Illinois Chicago · USUniversity of Illinois Urbana-Champaign · US

Funding

Vascular adhesion protein-1 (VAP-1) as a therapeutic target in strokeR01NS063279 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PELLIGRINO, DALE ALAN · 2010 to 2014
$1.7M
Astrocytes and neurovascular couplingR01HL088259 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PELLIGRINO, DALE ALAN · 2008 to 2011
$1.6M
NHLBI NIH HHS HL88259NHLBI NIH HHS R01 HL088259NINDS NIH HHS NS63279NINDS NIH HHS R01 NS063279
6 · The paper itself

Abstract

We examined the neuroprotective efficacy associated with post-ischemic vascular adhesion protein-1 (VAP-1) blockade in rats subjected to transient (1 h) middle cerebral artery occlusion (MCAo). We compared saline-treated control rats to rats treated with a highly selective VAP-1 inhibitor, LJP-1586 [Z-3-fluoro-2-(4-methoxybenzyl) allylamine hydrochloride]. Initial intraperitoneal LJP-1586 (or saline control) treatments were delayed until 6 h or 12 h reperfusion. At 72-h reperfusion, LJP-1586-treated rats displayed 51% and 33% smaller infarct volumes, relative to their controls, in the 6- and 12-h treatment groups, respectively. However, only in the 6-h treatment group was the infarct volume reduction significant (p < 0.05). On the other hand, we observed significantly improved neurologic functions in both 6- and 12-h treatment groups, versus their matched controls (p < 0.05). Also, the effect of 6-h LJP-1586 treatment on post-ischemic leukocyte trafficking in pial venules overlying the ischemic cortex was evaluated using intravital microscopy. These experiments revealed that: 1) LJP-1586 did not affect intravascular leukocyte (largely neutrophil) adhesion, at least out to 12-h reperfusion; and 2) the onset of neutrophil extravasation, which occurred between 6-8-h reperfusion in control rats, was prevented by LJP-1586-treatment. In conclusion, in rats subjected to transient MCAo, selective VAP-1 pharmacologic blockade provided neuroprotection, with a prolonged therapeutic window of 6-12-h reperfusion.

Indexed as

AllylamineAmine Oxidase (Copper-Containing)AnimalsBrain InfarctionCell Adhesion MoleculesCell MovementCerebrovascular CirculationDisease Models, AnimalInfarction, Middle Cerebral ArteryLaser-Doppler FlowmetryLeukocytesMaleMicroscopy, ConfocalNervous System DiseasesNeuroprotective AgentsRats3-fluoro-2-(4-methoxybenzyl)allylamineAllylamineAmine Oxidase (Copper-Containing)Cell Adhesion MoleculesNeuroprotective Agentsvascular adhesion protein-1, rat

Identifiers

PMID23050649
PMCPMC3481219
OpenAlexW2087769850

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.